Deep Relevance Regularization: Interpretable and Robust Tumor Typing of Imaging Mass Spectrometry Data
Christian Etmann, Maximilian Schmidt, Jens Behrmann, Tobias Boskamp,, Lena Hauberg-Lotte, Annette Peter, Rita Casadonte, J\"org Kriegsmann, Peter, Maass

TL;DR
This paper introduces Deep Relevance Regularization, a technique to improve neural network robustness and interpretability in tumor typing from imaging mass spectrometry data, especially across different laboratories.
Contribution
The paper proposes Deep Relevance Regularization to restrict neural network focus, enhancing robustness against confounding factors and improving interpretability in multi-lab tumor classification.
Findings
Improves classification accuracy across labs
Produces sparser, more interpretable relevance maps
Enhances robustness to confounding factors
Abstract
Neural networks have recently been established as a viable classification method for imaging mass spectrometry data for tumor typing. For multi-laboratory scenarios however, certain confounding factors may strongly impede their performance. In this work, we introduce Deep Relevance Regularization, a method of restricting what the neural network can focus on during classification, in order to improve the classification performance. We demonstrate how Deep Relevance Regularization robustifies neural networks against confounding factors on a challenging inter-lab dataset consisting of breast and ovarian carcinoma. We further show that this makes the relevance map -- a way of visualizing the discriminative parts of the mass spectrum -- sparser, thereby making the classifier easier to interpret
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMetabolomics and Mass Spectrometry Studies · Machine Learning in Materials Science · Computational Drug Discovery Methods
